General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Over the last 20 years, haematopoietic stem cell transplantation (HSCT) has been used to treat patients with severe autoimmune and inflammatory diseases whose response to standard treatment options has been limited, resulting in a poor long-term prognosis in terms of survival or disability. The vast...

Descripción completa

Detalles Bibliográficos
Autores principales: Jessop, Helen, Farge, Dominique, Saccardi, Riccardo, Alexander, Tobias, Rovira, Montserrat, Sharrack, Basil, Greco, Raffaella, Wulffraat, Nico, Moore, John, Kazmi, Majid, Badoglio, Manuela, Adams, Gillian, Verhoeven, Bregje, Murray, John, Snowden, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760538/
https://www.ncbi.nlm.nih.gov/pubmed/30705338
http://dx.doi.org/10.1038/s41409-019-0430-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760538/
https://www.ncbi.nlm.nih.gov/pubmed/30705338
http://dx.doi.org/10.1038/s41409-019-0430-7

Ejemplares similares